Title : Influence of the folate pathway and transporter polymorphisms on methotrexate treatment outcome in osteosarcoma.

Pub. Date : 2014 Oct

PMID : 25098908






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: Polymorphic SLCO1B1 rs4149056 and rs11045879 alleles were associated with significantly higher serum methotrexate area under the curve (P=0.001 and 0.011, respectively). Methotrexate solute carrier organic anion transporter family member 1B1 Homo sapiens
2 CONCLUSION: We have shown that SLCO1B1 polymorphisms influence methotrexate disposition and survival in methotrexate-treated osteosarcoma patients and therefore might serve as pharmacogenetic markers of treatment outcome. Methotrexate solute carrier organic anion transporter family member 1B1 Homo sapiens
3 CONCLUSION: We have shown that SLCO1B1 polymorphisms influence methotrexate disposition and survival in methotrexate-treated osteosarcoma patients and therefore might serve as pharmacogenetic markers of treatment outcome. Methotrexate solute carrier organic anion transporter family member 1B1 Homo sapiens